Compare CURX & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURX | SONM |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 7.5M |
| IPO Year | 2025 | 2019 |
| Metric | CURX | SONM |
|---|---|---|
| Price | $0.39 | $4.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.5M | 20.1K |
| Earning Date | 09-09-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $58,298,000.00 |
| Revenue This Year | N/A | $127.68 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.26 | $0.52 |
| 52 Week High | $9.18 | $12.30 |
| Indicator | CURX | SONM |
|---|---|---|
| Relative Strength Index (RSI) | 54.41 | 41.61 |
| Support Level | $0.39 | $0.66 |
| Resistance Level | $0.42 | $7.08 |
| Average True Range (ATR) | 0.06 | 0.58 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 29.85 | 9.48 |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
DNA X Inc operates a digital asset management platform.